The promise of immunotherapy in head and neck squamous cell carcinoma (Q26744433)

head and neck squamous cell carcinoma

Europe PubMed Central

title

The promise of immunotherapy in head and neck squamous cell carcinoma (English)

0 references

1 reference

1 reference

P Economopoulou

1

0 references

S Agelaki

2

0 references

C Perisanidis

3

0 references

E I Giotakis

4

0 references

A Psyrri

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells

5

0 references

language of work or name

English

0 references

publication date

September 2016

0 references

published in

Annals of Oncology

0 references

volume

27

0 references

issue

9

0 references

page(s)

1675-85

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Ten years of progress in head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Rational combinations of immunotherapeutics that target discrete pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immunity in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immunotherapy of human papilloma virus induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immune suppression in head and neck cancers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Promising systemic immunotherapies in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immune alterations and immunotherapy prospects in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Radiation triggering immune response and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

The effect of radiation on the immune response to cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Dose-dense chemotherapy improves mechanisms of antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

21 January 2018

PD-1/PD-L1 inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Nivolumab in combination with ipilimumab for the treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Combining radiation and immunotherapy: a new systemic therapy for solid tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

7 January 2021

Irradiation increases levels of GM-CSF through RNA stabilization which requires an AU-rich region in cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

7 January 2021

Gamma-irradiation-induced intercellular adhesion molecule-1 (ICAM-1) expression is associated with catalase: activation of Ap-1 and JNK

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

7 January 2021

Preconditioning chemotherapy with cisplatin enhances the antitumor activity of cytokine-induced killer cells in a murine melanoma model

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

7 January 2021

Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDW226

7 January 2021